BACKGROUND: Use of antihypertensive medications is common after intracerebral hemorrhage (ICH). Medications that block adrenergic activation (e.g., beta-blockers and the alpha(2)-agonist, clonidine) may reduce the inflammatory response and therefore have secondary benefit after ICH. METHODS: The patients with acute ICH enrolled in theplacebo arm of the CHANT trial were included. Univariate and multivariate analyses were undertaken for factors associated with blood pressure medication use, edema at 72 h, and clinical outcome at 90 days. RESULTS: Of the 303 patients, 87.8% received some antihypertensive treatment during the first 72 h of hospitalization. Edema volume on neuroimaging at 72 h was independently associated with clinical outcome. Use of anti-adrenergic medications was associated with less edema after controlling for hemorrhage volume and blood pressure. CONCLUSIONS:Antihypertensive medications that antagonize the sympathetic nervous system may reduce perihematomal edema after ICH.
RCT Entities:
BACKGROUND: Use of antihypertensive medications is common after intracerebral hemorrhage (ICH). Medications that block adrenergic activation (e.g., beta-blockers and the alpha(2)-agonist, clonidine) may reduce the inflammatory response and therefore have secondary benefit after ICH. METHODS: The patients with acute ICH enrolled in the placebo arm of the CHANT trial were included. Univariate and multivariate analyses were undertaken for factors associated with blood pressure medication use, edema at 72 h, and clinical outcome at 90 days. RESULTS: Of the 303 patients, 87.8% received some antihypertensive treatment during the first 72 h of hospitalization. Edema volume on neuroimaging at 72 h was independently associated with clinical outcome. Use of anti-adrenergic medications was associated with less edema after controlling for hemorrhage volume and blood pressure. CONCLUSIONS: Antihypertensive medications that antagonize the sympathetic nervous system may reduce perihematomal edema after ICH.
Authors: Bryan A Cotton; Kimberly B Snodgrass; Sloan B Fleming; Robert O Carpenter; Clinton D Kemp; Patrick G Arbogast; John A Morris Journal: J Trauma Date: 2007-01
Authors: Kenji Inaba; Pedro G R Teixeira; Jean-Stephane David; Linda S Chan; Ali Salim; Carlos Brown; Timothy Browder; Elizabeth Beale; Peter Rhee; Demetrios Demetriades Journal: J Am Coll Surg Date: 2007-11-26 Impact factor: 6.113
Authors: Wang Gai Qing; Yang Qi Dong; Tang Qing Ping; Li Guang Lai; Li Dong Fang; Hu Wei Min; Lian Xia; Pei Yu Heng Journal: J Neurosurg Date: 2009-03 Impact factor: 5.115
Authors: Konstantin Prass; Christian Meisel; Conny Höflich; Johann Braun; Elke Halle; Tilo Wolf; Karsten Ruscher; Ilya V Victorov; Josef Priller; Ulrich Dirnagl; Hans-Dieter Volk; Andreas Meisel Journal: J Exp Med Date: 2003-08-25 Impact factor: 14.307
Authors: Sebastian Urday; Lauren A Beslow; Feng Dai; Fan Zhang; Thomas W K Battey; Anastasia Vashkevich; Alison M Ayres; Audrey C Leasure; Magdy H Selim; J Marc Simard; Jonathan Rosand; W Taylor Kimberly; Kevin N Sheth Journal: Crit Care Med Date: 2016-04 Impact factor: 7.598
Authors: Sebastian Urday; W Taylor Kimberly; Lauren A Beslow; Alexander O Vortmeyer; Magdy H Selim; Jonathan Rosand; J Marc Simard; Kevin N Sheth Journal: Nat Rev Neurol Date: 2015-01-27 Impact factor: 42.937
Authors: Santiago Ortega-Gutierrez; Jiz Thomas; Andres Reccius; Sachin Agarwal; Hector Lantigua; Min Li; Amanda M Carpenter; Stephan A Mayer; J Michael Schmidt; Kiwon Lee; Jan Claassen; Neeraj Badjatia; Christine Lesch Journal: Neurocrit Care Date: 2013-02 Impact factor: 3.210
Authors: Audrey Leasure; W Taylor Kimberly; Lauren H Sansing; Kristopher T Kahle; Golo Kronenberg; Hagen Kunte; J Marc Simard; Kevin N Sheth Journal: Curr Treat Options Neurol Date: 2016-02 Impact factor: 3.598
Authors: Michael Moussouttas; Thanh T Huynh; John Khoury; Edwin W Lai; Keith Dombrowski; Scott Pello; Karel Pacak Journal: Cerebrovasc Dis Date: 2012-01-05 Impact factor: 2.762